Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsugikazu Komoda

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 22, 2011
[Relationship between the effects of a high-fat meal and blood group in determination of alkaline phosphatase activity]Makoto Matsushita, Tsugikazu Komoda
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 30, 2002
The effect of different buffers and amounts of intestinal alkaline phosphatase isoforms on total alkaline phosphatase activityMakoto Matsushita, Tsutomu Irino, Takeshi Kawaguchi, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 22, 2005
[Incidence and characteristics of intestinal hyperphosphatasemia in healthy subjects]Makoto Matsushita, Tsutomu Irino, Kiyoshi Kamiyama, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 27, 2002
Detection of oxidized high-density lipoproteinToshiyuki Matsunaga, Iwao Koyama, Shigeru Hokari, et al.
Journal of Cellular Biochemistry|September 17, 2004
Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized ratsTakashi Miyazaki, Toshiyuki Matsunaga, Shuichi Miyazaki, et al.
Clinical Biochemistry|November 5, 2002
Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylationIwao Koyama, Toshiyuki Matsunaga, Tsuyoshi Harada, et al.
Biochemical and Biophysical Research Communications|March 21, 2003
NF-kappa B activation in endothelial cells treated with oxidized high-density lipoproteinToshiyuki Matsunaga, Shigeru Hokari, Iwao Koyama, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 27, 2007
[Estimation of blood-group-dependent hyperphosphatasemia in healthy subjects by agarose gel electrophoresis]Makoto Matsushita, Tsutomu Irino, Hitomi Kase, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 1, 2003
Blood extracellular superoxide dismutase levels in hemodialysis patients pre- and post-hemodialysis and its association with lipoprotein lipase mass and free fatty acidHiroji Shimomura, Eisuke Maehata, Tomi Takamiya, et al.
Hybridoma and Hybridomics|August 8, 2002
Characterization of four monoclonal antibodies to recombinant human tartrate-resistant acid phosphataseTakashi Miyazaki, Toshiyuki Matsunaga, Shuichi Miyazaki, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 22, 2011
[Relationship between the effects of a high-fat meal and blood group in determination of alkaline phosphatase activity]Makoto Matsushita, Tsugikazu Komoda
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 30, 2002
The effect of different buffers and amounts of intestinal alkaline phosphatase isoforms on total alkaline phosphatase activityMakoto Matsushita, Tsutomu Irino, Takeshi Kawaguchi, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 22, 2005
[Incidence and characteristics of intestinal hyperphosphatasemia in healthy subjects]Makoto Matsushita, Tsutomu Irino, Kiyoshi Kamiyama, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 27, 2002
Detection of oxidized high-density lipoproteinToshiyuki Matsunaga, Iwao Koyama, Shigeru Hokari, et al.
Journal of Cellular Biochemistry|September 17, 2004
Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized ratsTakashi Miyazaki, Toshiyuki Matsunaga, Shuichi Miyazaki, et al.
Clinical Biochemistry|November 5, 2002
Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylationIwao Koyama, Toshiyuki Matsunaga, Tsuyoshi Harada, et al.
Biochemical and Biophysical Research Communications|March 21, 2003
NF-kappa B activation in endothelial cells treated with oxidized high-density lipoproteinToshiyuki Matsunaga, Shigeru Hokari, Iwao Koyama, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 27, 2007
[Estimation of blood-group-dependent hyperphosphatasemia in healthy subjects by agarose gel electrophoresis]Makoto Matsushita, Tsutomu Irino, Hitomi Kase, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 1, 2003
Blood extracellular superoxide dismutase levels in hemodialysis patients pre- and post-hemodialysis and its association with lipoprotein lipase mass and free fatty acidHiroji Shimomura, Eisuke Maehata, Tomi Takamiya, et al.
Hybridoma and Hybridomics|August 8, 2002
Characterization of four monoclonal antibodies to recombinant human tartrate-resistant acid phosphataseTakashi Miyazaki, Toshiyuki Matsunaga, Shuichi Miyazaki, et al.
Pageof 6